Diagnostic Biomarkers to Correlate Molecular Changes and Inflammatory Cascade in the Dental Pulp.

NCT ID: NCT05464797

Last Updated: 2022-07-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

48 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-12-12

Study Completion Date

2022-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aimed to evaluate the molecular changes that occur within the pulp tissue during inflammation and its correlation with vital pulp therapy with its different treatment modalities (Direct pulp capping, Partial Pulpotomy and Complete Pulpotomy).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The diagnosis of irreversible pulpitis was based only on the clinical signs and symptoms which does not always match that of the histological changes of the pulp tissues. So, it is more appropriate to diagnose the pulp according to the molecular changes taking place throughout the pulp tissues. Different studies have been conducted to study the molecular changes that take place in the inflamed pulp, Including a study that was conducted by Rechenberg et al in 2014 which states different locations to obtain samples for these molecules. The best of which was the dental pulp blood sample. Many studies stated the way to obtain a blood sample from the pulp and how to prepare and test it to evaluate the levels and concentrations of different inflammatory molecules. Many studies were also conducted to study the different changes and accurateness of measurement of different molecules.

The pulp inflammation occurs in a low compliance environment of dentinal walls. So, During acute inflammatory reaction, Vasodilatation occurs along with increased capillary permeability, Which leads to increase in the pulp interstitial fluid pressure which creates more pressure on blood vessels and this prevents beneficial blood flow, which decreases the ability of the pulp to defend itself from bacterial attacks causing tissue necrosis. This necrotic tissue is colonized by bacterial tissues.

In the literature, one of the novel treatment modalities for irrevesible inflammation of the pulp is partial removal of the inflammed pulp tissue according to clinical sign (bleeding control), The pulp tissue is removed partially until reaching complete coronal pulp removal or complete pulpectomy until hemostasis is obtained after 10 minutes of moist cotton pellet application.So, The normal pulp is preserved.

In 2019, Ricucci et al conducted a systematic review for treatment of deep carious lesions with pulp exposure. With treatment modalities ranging from direct pulp capping, partial pulpotomy, complete pulpotomy and pulpectomy. Based only on clinical signs of normal appearance of the pulp tissue under magnification with dental operating microscope and bleeding control within 10 minutes with a moist cotton pellet.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Vital Pulp Therapy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control group

Group Type PLACEBO_COMPARATOR

Cytokines level in pulpal blood.

Intervention Type DIAGNOSTIC_TEST

Measuring the concentration of IL-8 and MMP-9 in the dental pulp during inflammation.

Direct Pulp Capping group

Group Type EXPERIMENTAL

Pulp therapy

Intervention Type PROCEDURE

partial or complete removal of inflamed pulp tissue

Cytokines level in pulpal blood.

Intervention Type DIAGNOSTIC_TEST

Measuring the concentration of IL-8 and MMP-9 in the dental pulp during inflammation.

Partial Pulpotomy group

Group Type EXPERIMENTAL

Pulp therapy

Intervention Type PROCEDURE

partial or complete removal of inflamed pulp tissue

Cytokines level in pulpal blood.

Intervention Type DIAGNOSTIC_TEST

Measuring the concentration of IL-8 and MMP-9 in the dental pulp during inflammation.

Complete Pulpotomy group

Group Type EXPERIMENTAL

Pulp therapy

Intervention Type PROCEDURE

partial or complete removal of inflamed pulp tissue

Cytokines level in pulpal blood.

Intervention Type DIAGNOSTIC_TEST

Measuring the concentration of IL-8 and MMP-9 in the dental pulp during inflammation.

Root canal treatment group

Group Type EXPERIMENTAL

Pulp therapy

Intervention Type PROCEDURE

partial or complete removal of inflamed pulp tissue

Cytokines level in pulpal blood.

Intervention Type DIAGNOSTIC_TEST

Measuring the concentration of IL-8 and MMP-9 in the dental pulp during inflammation.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Pulp therapy

partial or complete removal of inflamed pulp tissue

Intervention Type PROCEDURE

Cytokines level in pulpal blood.

Measuring the concentration of IL-8 and MMP-9 in the dental pulp during inflammation.

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Positive response to cold testing.
* The age range from 15-45 years.
* Patients of both sex.
* Has clinical symptoms of pulpitis with normal apical tissues and supported by radiographic evaluation with no periradicular changes.

Exclusion Criteria

* Patients over 45 years of age.
* Patients with clinical symptoms of periradicular inflammation or periradicular radiographic changes.
* Negative response to cold testing.
Minimum Eligible Age

15 Years

Maximum Eligible Age

45 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Mansoura University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Mansoura University

Al Mansurah, Dakahliya, Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

M02031120

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

New Vital Pulpotomy Medications in Primary Molars
NCT05937100 ACTIVE_NOT_RECRUITING NA
Direct Pulp Capping in Primary Molars
NCT05530954 COMPLETED PHASE3
Evaluation of Pulpal Biomarkers in Vital Pulp Therapy
NCT07073573 ACTIVE_NOT_RECRUITING NA